- AAVE holds above $90 as protocol deposits rise, but retail demand weakens
- Cardano (ADA) Price Eyes Breakout as Bulls Challenge Key Resistance Near $0.22
- ATOM Price Leads DeFi Rally as Traders Bet on Cosmos Recovery
- U.S. stocks move丨Zebra Technologies rises over 11% in pre-market trading
- UBS Group: Adidas target price lowered from 219 euros to 173 euros.
- US ISM Manufacturing PMI Hits 4-Year High; Stock and Crypto Markets Eye Rally
- Haverty Furniture 2Q Sales $194.9M >HVT
- Haverty Furniture 2Q Net $5.31M >HVT
- Snap Inc. Stock Jumps 5% on 19% Revenue Growth, Hits Key Resistance
- IDEXX Labs Sees 2026 Rev $4.7B-$4.745B >IDXX
- Apollo Global 2Q EPS $2.15 >APO
- Apollo Global 2Q Adj EPS $2.11 >APO
- Apollo Global 2Q Rev $11.15B >APO
- Apollo Global 2Q Spread-Related Earnings $877M, or $1.41/Share >APO
- Apollo Global 2Q Fee-Related Earnings $785M, or $1.26/Share >APO
- Apollo Global Total Assets Under Management as of June 30 $1.05 Trillion >APO
- Apollo Global Declares Qtr Dividend of 56.25c/Share >APO
- Apollo Global: Our Strong 2Q Results Reflect Record Earnings Across Asset Management and Retirement Services >APO
- Westlake 2Q EBITDA $679M >WLK
- Enpro Sees 2026 Rev $330M-$340M >NPO
- Trex: Additional $150M Stock Buyback Approved
- Trex Co 2Q Net $61.9M >TREX
- Graphic Packaging 2Q Net $24M >GPK
- Vivid Seats 2Q Rev $129.9M >SEAT
- U.S. Political, Economic Calendar - Week Ahead -2-
- Kimberly-Clark 2Q International Personal Care Net Sales $1.5B, Up 4% >KMB
- Hyperscale Data Sees 2027 Rev $300M-$350M >GPUS
- Chatham Lodging Trust 2Q EPS 13c >CLDT
- Kimberly-Clark 2Q Adj EPS From Cont Ops $1.80 >KMB
- Kimberly-Clark: 2026 Adj. EPS Attributable to Co Are Expected to See Low-Single-Digit Decline on Constant-Currency Basis >KMB
- Kimberly-Clark: 2026 Adj EPS From Cont Ops Expected to Grow High Single Digits on Constant-Currency Basis Including an About 30% Increase in Income From Equity Cos Vs Yr-Ago >KMB
- Kimberly-Clark: 2026 Adjusted Operating Profit Now Expected to Grow Mid-Single Digits on Constant-Currency Basis >KMB
- Kimberly-Clark Now Sees 2026 Organic Sales Growth to Be About 100 Basis Points Below Its Weighted Average Category Growth in Categories and Countries It Competes, Currently 2% on Trailing 12-Month Basis >KMB
- Kimberly-Clark: 2Q North America Net Sales Includes 0.5% Impact From Exit of CO's Private Label Diaper Business in US >KMB
- Kimberly-Clark: 2Q North America Net Sales $2.7B, Down 1.2% >KMB
- Kimberly-Clark: Situation Expected to Further Impact Sales and Profit in Near Term >KMB
- Kimberly-Clark: Independent Testing Conducted by Government-Certified Third Party Confirmed Quality and Safety of Co's Products, Refuting the False Allegations >KMB
- Kimberly-Clark 2Q Organic Sales Growth Broadly in Line With Prior Year >KMB
- Kimberly-Clark: 2Q Sales Rose 0.6% as Favorable Currency Impacts of 1.1% Were Partially Offset by Exit of CO's Private Label Diaper Business in US >KMB
- InfuSystem 2Q Rev $36.9M >INFU
- Kimberly-Clark 2Q Cont Ops EPS $1.22 >KMB
- Kimberly-Clark 2Q Adj EPS $2.12 >KMB
- Kimberly-Clark 2Q Sales $4.19B >KMB
- Kimberly-Clark 2Q EPS $1.04 >KMB
- Merck: MK-4208, Formerly TERN-701, Is Novel Investigational Oral Allosteric BCR::ABL1 Tyrosine Kinase Inhibitor Recently Granted BTD by FDA for Treatment of Certain Adults With Philadelphia Chromosome-Positive Chronic Myeloid Leukemia >MRK
- IDEXX Labs 2Q EPS $4.27 >IDXX
- Westlake 2Q Sales $3.27B >WLK
- Enpro 2Q EPS $1.27 >NPO
- Trex Co 2Q EPS 60c >TREX
- Chatham Lodging Trust 2Q Net $8.21M >CLDT
- InfuSystem 2Q Net $3.23M >INFU
- InfuSystem 2Q EPS 15c >INFU
- Willis Lease Finance 2Q EPS $1.31 >WLFC
- Zebra 2Q EPS $4.85 >ZBRA
- Westlake Chemical Ptrs 2Q Net $14.2M >WLKP
- IDEXX Labs 2Q Net $338.4M >IDXX
- Westlake 2Q EPS $2.01 >WLK
- Enpro 2Q Adj EPS $2.50 >NPO
- Trex Co 2Q Sales $418M >TREX
- Revvity Raises FY View To Rev $2.83B-Negative $2.86B >RVTY
- Waters Corp Sees 2026 Organic Constant-Currency Revenue Growth 7%-9% >WAT
- Ares Commercial Real Est 2Q Rev $14.4M >ACRE
- Ball Corp 2Q Adj EPS $1.03 >BALL
- Ares Commercial Real Est 2Q Net $4.38M >ACRE
- Ares Commercial Real Est 2Q EPS 8c >ACRE
- Leidos Holdings 2Q Adj EPS $3.26 >LDOS
- Leidos Holdings 2Q Rev $4.56B >LDOS
- Leidos Holdings 2Q EPS $2.81 >LDOS
- Leidos Holdings 2Q Net Bookings $4.9B >LDOS
- Leidos Holdings Sees FY Rev $18.2B-$18.4B >LDOS
- Waters Corp Sees 3Q Rev $1.75B-$1.76B >WAT
- Waters Corp 2Q Adj EPS $3.05 >WAT
- Waters Corp Sees 3Q Adj EPS $3.95-Adj EPS $4.05 >WAT
- Waters Corp 2Q Loss/Shr $1.39 >WAT
- Waters Corp Sees FY Rev $6.42B-$6.48B >WAT
- Waters Corp 2Q Rev $1.65B >WAT
- Waters Corp Sees FY Adj EPS $14.45-Adj EPS $14.65 >WAT
- Ball Corp 2Q Cont Ops EPS 83c >BALL
- Ball Corp 2Q Sales $4B >BALL
- Ball Corp 2Q Net $221M >BALL
- Ball Corp 2Q EPS 83c >BALL
- DuPont De Nemours: Our Strong Execution and Market-Driven Growth Continue to Translate Into Higher Earnings and Free Cash Flow Generation >DD
- Katapult Holdings 2Q Rev $74.8M >KPLT
- DuPont De Nemours to Repurchase $250M of Shares in 3Q >DD
- DuPont De Nemours Now Sees FY26 Operating Ebitda $1.75B-$1.77B >DD
- DuPont De Nemours Raises FY26 View To Adj EPS $7.17-Adj EPS $7.32 Vs Prior View $2.35-$2.40 >DD
- DuPont De Nemours Narrows FY26 View To Sales $7.16B-$7.19B >DD
- DuPont De Nemours Sees 2H Adj EPS $3.65-Adj EPS $3.80 >DD
- DuPont De Nemours Sees 2H Operating Ebitda of $890M-$910M >DD
- DuPont De Nemours Sees 2H Sales $3.66B-$3.69B >DD
- DuPont De Nemours: With Continued Strength Across Healthcare, Industrial Water and Aerospace End-Markets, Expect Mid- Single Digit Organic Sales Growth in Second Half of Yr >DD
- DuPont De Nemours 2Q Sales $1.82B >DD
- DuPont De Nemours: 2Q Industrial Techn Sales Up Mid-Single Digits on Organic Basis on Continued Strength in Aerospace Coupled With Growth in Electric Vehicle Applications >DD
- DuPont De Nemours: 2Q Building Tech Sales Up Low-Single Digits on Organic Basis Due to Growth in Residential and Non-Residential Construction Markets >DD
- DuPont De Nemours 2Q Diversified Industrials Sales Rose 3% to $963M >DD
- DuPont De Nemours: 2Q Water Tech Sales Up Low-Single Digits on Organic Basis on Continued Strength in Industrial Water and Semiconductor Markets, Partially Offset by Weakness in Mideast >DD
- DuPont De Nemours: 2Q Healthcare Tech Sales Up Mid-Single Digits on Organic Basis on Broad-Based Growth Led by Personal Protection and Biopharma >DD
- DuPont De Nemours 2Q Transaction-Adjusted Free Cash Flow $326M >DD
- DuPont De Nemours 2Q Organic Sales Growth Up 4% >DD
- DuPont De Nemours 2Q Adj EPS $1.88 >DD